Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-22-021446

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 95,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Millar Kerri-Ann · CHIEF FINANCIAL OFFICER

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-02-09 Grant or award : show line 1 in the form Stock Option (right to buy) +85,000 85,000 D
2022-03-25 Grant or award : show line 2 in the form Stock Option (right to buy) +10,000 10,000 D
Loading xslF345X03/doc4.xml…